Amprion

• Russell Lebovitz

  Lead investigator

Sources: openalex.org

• Alzheimer's Drug Discovery Foundation

  Biomarkers, Evaluation of the Clinical Utility of α-Synuclein Seed Amplification Assay as an Aid in the Diagnosis of Dementia and Differentiation of Dementia Subtypes, ADDF-20965211, US$570.8k, 2023–2024, 11 Sept 2023

• Alzheimer's Drug Discovery Foundation

  Diagnostics Accelerator, Development and Commercialization of a Protein Misfolding Cyclic Amplification (PMCA) Clinical Test for Detection of Aggregates of Misfolded α-Synuclein in Plasma and Plasma Exosomes, ADDF-21187421, US$631.7k, 2020–2021, 15 Nov 2020

Sources: openalex.org

• Digital and traditional recruitment strategies and participation patterns in the multicenter Healthy Brain Ageing study

  Consulting or advice, Fees or honoraria, 5 Aug 2026

Sources: pubmed.ncbi.nlm.nih.gov